Mainz, Germany

Thomas Wolfel


Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 95(Granted Patents)


Location History:

  • Mainz, BE (1996 - 1998)
  • Mainz, DE (1996 - 1999)

Company Filing History:


Years Active: 1996-1999

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Thomas Wolfel

Introduction

Thomas Wolfel is a prominent inventor based in Mainz, Germany. He has made significant contributions to the field of cancer research, holding a total of 11 patents. His work primarily focuses on tumor rejection antigens, which play a crucial role in cancer immunotherapy.

Latest Patents

Among his latest patents is a groundbreaking invention related to nucleic acid molecules coding for a tumor rejection antigen precursor. This precursor, known as 'TRAP', is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. The ramifications of this discovery are significant, as they could lead to advancements in cancer treatment. Another notable patent involves an isolated nucleic acid sequence coding for a tumor rejection antigen, further emphasizing his innovative approach to cancer therapy.

Career Highlights

Throughout his career, Thomas Wolfel has worked with esteemed organizations such as the Ludwig Institute for Cancer Research Limited and the Ludwig Institute. His research has been pivotal in understanding how the immune system can be harnessed to fight cancer more effectively.

Collaborations

Thomas has collaborated with notable colleagues in the field, including Thierry R Boon-Falleur and Vincent Brichard. These partnerships have enhanced the impact of his research and contributed to the advancement of cancer immunotherapy.

Conclusion

Thomas Wolfel's contributions to cancer research through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for new therapeutic strategies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…